查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
淋病診斷藥市場- 成長，未來展望，競爭分析，2023年～2031年
市場調查報告書
商品編碼
1255993

淋病診斷藥市場- 成長，未來展望，競爭分析，2023年～2031年

Gonorrhea Diagnostics Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

淋病是由淋菌感染引起的，該感染會感染身體潮濕、溫暖的部位，例如陰道、肛門、尿道、喉嚨和眼睛。淋病是第二種最常見的性傳播疾病 (STD)，因為可以透過無保護措施的性行為或有多個性伴侶傳播。由於頭孢菌素耐藥性淋病的高流行率和高威脅性，有必要瞭解淋病的流行病學。由於疾病控制和預防中心2016年報告中引用的最新研究，全球淋病患病率為每10萬人142.1例。與男性相比，女性的發病率更高，並且在北美、拉丁美洲、非洲和南亞其他發展中國家等地區廣泛流行。

目錄

第1章 序文

  • 報告內容
    • 報告書的目的
    • 主要讀者
    • 主要的供應商品
  • 市場區隔
  • 調查手法
    • I期-二次調查
    • II期-一次調查
    • III期-各專家檢討
    • 前提條件
    • 採用的方法

第2章 摘要整理

  • 市場概述:全球淋病診斷藥市場
  • 全球淋病診斷藥市場:各類型 2022
  • 全球淋病診斷藥市場:各地區 2022
  • 富有魅力的投資提案:各地區 2022

第3章 淋病診斷藥市場:競爭分析

  • 主要供應商的市場定位
  • 供應商採用的策略
  • 主要的產業策略
  • 等級分析:2022 vs. 2031

第4章 淋病診斷藥市場:常量分析和市場動態

  • 簡介
  • 全球淋病診斷藥市場金額 2021-2031
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • See-Saw分析

第5章 淋病診斷藥市場:各類型 2021-2031

  • 市場概要
  • 成長、收益分析:2022 vs. 2031
  • 市場區隔
    • 流式細胞技術
    • 影像診斷
    • 凝膠微小液水滴
    • 層析法
    • 微脂體
    • 單株抗體檢驗
    • 動態光散射
    • 分子診斷檢驗
      • 拭子測試
      • 核酸擴增實驗(NAAT)

第6章 北美的淋病診斷藥市場 2021-2031

  • 市場概要
  • 淋病診斷藥市場:各類型 2021-2031
  • 淋病診斷藥市場:各地區 2021-2031
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第7章 英國歐洲聯盟淋病診斷藥市場 2021-2031

  • 市場概要
  • 淋病診斷藥市場:各類型 2021-2031
  • 淋病診斷藥市場:各地區 2021-2031
    • 英國和歐洲聯盟
      • 英國
      • 德國
      • 西班牙
      • 義大利
      • 法國
      • 其他歐洲地區

第8章 亞太地區的淋病診斷藥市場 2021-2031

  • 市場概要
  • 淋病診斷藥市場:各類型 2021-2031
  • 淋病診斷藥市場:各地區 2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 其他亞太地區

第9章 南美的淋病診斷藥市場 2021-2031

  • 市場概要
  • 淋病診斷藥市場:各類型 2021-2031
  • 淋病診斷藥市場:各地區 2021-2031
    • 南美
      • 巴西
      • 墨西哥
      • 其他南美國家地區

第10章 中東、非洲的淋病診斷藥市場 2021-2031

  • 市場概要
  • 淋病診斷藥市場:各類型 2021-2031
  • 淋病診斷藥市場:各地區 2021-2031
    • 中東、非洲
      • GCC
      • 非洲
      • 其他中東、非洲地區

第11章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies
  • Beckman Coulter Inc.
  • Becton Dickinson & Company
  • bioMerieux Inc.
  • Cepheid Inc.
  • F. Hoffmann-La Roche AG
  • Ortho Clinical Diagnostics
  • PerkinElmer Inc.
  • Pfizer Inc.
  • Roche Diagnostics
  • Siemens AG
  • Tosoh Corporation
  • Others notable players
Product Code: 137976-01-23

Gonorrhea is caused due to the infection of bacterium Neisseria gonorrhea which usually affects the moist and warm areas of the body such as vagina, anus, urethra, throat and eyes. It is classified as the second most occurring sexually transmitted disease (STD) as it has the risk to spread through unprotected sex or having multiple sex partners. Due to high morbidity rate and eminent threat of gonorrhea being resistant to cephalosporin, makes it necessary to understand the disease epidemiology of gonorrhea. As per the latest research citing of the Centers for Disease Control and Prevention's 2016 report, the global prevalence of gonorrhea is 142.1 cases per 100,000 people. The occurrence is high in women in comparison to men and widely prevalent in regions such as North America, Latin America, Africa and other developing nations of South Asia.

The World Health Organization has postulated a treatment guideline for gonorrhea in order to overcome problem of microbial resistance, which consists of use of antibiotics such as third generation cephalosporins, doxycycline, azithromycin, gemifloxacin etc. For effective diagnosis of gonorrhea, cell culture standard test is considered as gold standard due to inherent features such as high specificity, high sensitivity and relatively low cost. The problems associated with cell culture of Neisseria is the need to maintain the bacterial viability during storage and transport, and approximately 24-72 hours are required before a preliminary culture test result is obtained. Nucleic acid amplification test (NAAT) has been approved by the USFDA for analyzing genital specimen only, and has been beneficial to gain positive results with very less genetic material, urine samples and vaginal swabs. For analyzing extra genital specimen, gonorrhea diagnosis is performed with serological tests, monoclonal antibodies tests, and flow cytometry etc.

Key players identified for gonorrhea diagnostics market includes:

Abbott Laboratories, Agilent Technologies, Beckman Coulter, Inc., Becton Dickinson & Company, bioMerieux, Inc., Cepheid, Inc., F. Hoffmann-La Roche AG, Ortho Clinical Diagnostics, PerkinElmer, Inc., Pfizer, Inc., Roche Diagnostics, Siemens AG, Tosoh Corporation and Others notable players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Gonorrhea Diagnostics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Gonorrhea Diagnostics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

Flow Cytometry

Diagnostic Imaging

Gel Microdroplets

Chromatography

Liposomes

Monoclonal Antibodies Tests

Differential Light Scattering

Molecular Diagnostic Tests

Swab Tests

Nucleic Acid Amplification Tests (NAAT)

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Gonorrhea Diagnostics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Gonorrhea Diagnostics market?

Which is the largest regional market for Gonorrhea Diagnostics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Gonorrhea Diagnostics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Gonorrhea Diagnostics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Gonorrhea Diagnostics Market
  • 2.2. Global Gonorrhea Diagnostics Market, By Type, 2022 (US$ Million)
  • 2.3. Global Gonorrhea Diagnostics Market, By Geography, 2022 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2022

3. Gonorrhea Diagnostics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Gonorrhea Diagnostics Market Vendors
  • 3.2. Strategies Adopted by Gonorrhea Diagnostics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Gonorrhea Diagnostics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Gonorrhea Diagnostics Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Flow Cytometry
    • 5.3.2. Diagnostic Imaging
    • 5.3.3. Gel Microdroplets
    • 5.3.4. Chromatography
    • 5.3.5. Liposomes
    • 5.3.6. Monoclonal Antibodies Tests
    • 5.3.7. Differential Light Scattering
    • 5.3.8. Molecular Diagnostic Tests
      • 5.3.8.1. Swab Tests
      • 5.3.8.2. Nucleic Acid Amplification Tests (NAAT)

6. North America Gonorrhea Diagnostics Market, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
  • 6.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

7. UK and European Union Gonorrhea Diagnostics Market, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
  • 7.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

8. Asia Pacific Gonorrhea Diagnostics Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
  • 8.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

9. Latin America Gonorrhea Diagnostics Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
  • 9.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

10. Middle East and Africa Gonorrhea Diagnostics Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
  • 10.3.Gonorrhea Diagnostics Market: By Region, 2021-2031, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Gonorrhea Diagnostics Market: By Type, 2021-2031, USD (Million)

11. Company Profile

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Agilent Technologies
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Beckman Coulter, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Becton Dickinson & Company
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. bioMerieux, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Cepheid, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. F. Hoffmann-La Roche AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Ortho Clinical Diagnostics
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. PerkinElmer, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Pfizer, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Roche Diagnostics
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. Siemens AG
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives
  • 11.13. Tosoh Corporation
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Portfolio
    • 11.13.4. Strategic Initiatives
  • 11.14. Others notable players
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Portfolio
    • 11.14.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 2 Global Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 3 North America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 4 North America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 5 U.S. Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 6 U.S. Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 7 Canada Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 8 Canada Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 9 Rest of North America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 10 Rest of North America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 11 UK and European Union Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 12 UK and European Union Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 13 UK Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 14 UK Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 15 Germany Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 16 Germany Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 17 Spain Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 18 Spain Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 19 Italy Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 20 Italy Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 21 France Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 22 France Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 23 Rest of Europe Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 24 Rest of Europe Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 25 Asia Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 26 Asia Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 27 China Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 28 China Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 29 Japan Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 30 Japan Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 31 India Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 32 India Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 33 Australia Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 34 Australia Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 35 South Korea Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 36 South Korea Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 37 Latin America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 38 Latin America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 39 Brazil Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 40 Brazil Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 41 Mexico Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 42 Mexico Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 43 Rest of Latin America Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 44 Rest of Latin America Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 45 Middle East and Africa Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 46 Middle East and Africa Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 47 GCC Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 48 GCC Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 49 Africa Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 50 Africa Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)
  • TABLE 51 Rest of Middle East and Africa Gonorrhea Diagnostics Market By Type, 2021-2031, USD (Million)
  • TABLE 52 Rest of Middle East and Africa Gonorrhea Diagnostics Market By Molecular Diagnostic Tests, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Gonorrhea Diagnostics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Gonorrhea Diagnostics Market: Quality Assurance
  • FIG. 5 Global Gonorrhea Diagnostics Market, By Type, 2022
  • FIG. 6 Global Gonorrhea Diagnostics Market, By Geography, 2022
  • FIG. 7 Market Geographical Opportunity Matrix - Global Gonorrhea Diagnostics Market, 2022
  • FIG. 8 Market Positioning of Key Gonorrhea Diagnostics Market Players, 2022
  • FIG. 9 Global Gonorrhea Diagnostics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 10 Global Gonorrhea Diagnostics Market, By Type, 2022 Vs 2031, %
  • FIG. 11 U.S. Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 12 Canada Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 13 Rest of North America Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 14 UK Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 15 Germany Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 16 Spain Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 17 Italy Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 18 France Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of Europe Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 20 China Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 21 Japan Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 22 India Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 23 Australia Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 24 South Korea Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Asia Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 26 Brazil Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 27 Mexico Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 28 Rest of Latin America Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 29 GCC Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 30 Africa Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Middle East and Africa Gonorrhea Diagnostics Market (US$ Million), 2021 - 2031